Pharmaceutical Excipients Market to Surpass US $9.8 Billion by 2024
Excipients plays a vital part in drug dosage formulation as they are mixed with active pharmaceutical ingredients that forms the volume for any pharmaceutical product. Pharmaceutical excipients possess various properties that are utilized by API for making bulk of any product and can also improve drugs bioavailability in certain cases. Though there are various types of pharmaceutical excipients, only particular excipients are most compatible for a specific dosage form. Pharmaceutical excipients do not have same properties as API, though they need to be stabilized and standardized before use. In 2016, according to an update from William Reed Business Media Ltd., the IPEC association of China was included as the fifth member of global excipient certification organization.This inclusion is expected to favor the promotion of safety regarding excipients throughout the supply chain in China.
To know the latest trends and insights prevalent in the pharmaceutical excipients market, click the link below: https://www.coherentmarketinsights.com/market-insight/pharmaceutical-excipients-market-124
New product development incurs a significant amount of effort and time along with high cost expenditure. However, product development in pharmaceutical excipients is economical as compared to drug or API development. Quality by design is a scientific method that also involves risk-based approach at product concept stage. In 2002, the U.S. Food and Drug Administration (FDA) started an initiative for pharmaceutical companies called pharmaceutical current good manufacturing Practices (GMP). This was considered to be a risk-based approach that encouraged various organizations involved in pharmaceutical product manufacturing to adopt management techniques to enhance quality in keeping with modern standards. Furthermore, companies are now focused towards expanding their geographical reach by setting up new plants and manufacturing units worldwide based on the potential of the region. For instance, in 2016, according to William Reed Business Media Ltd update, Ashland Inc., established a new pharmaceutical excipients manufacturing unit in Nanjing, China, in order to cater to rise in local demand and new quality regulations. This would provide a major stronghold for the company in the region.
Get Free PDF Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/124
The market for pharmaceutical excipients is expected to grow significantly over the forecast period. Since pharmaceutical excipients play an important role in the finished pharmaceutical products, varying pharmaceutical products require different forms of excipients. According to Saffron Media Pvt. Ltd, in 2014, there were around 1,200 excipients available in the market that were used in the pharmaceutical industry for product development. However, there is still need for more variations in the properties of excipients to meet emerging needs. This can be achieved by using multifunctional excipients that include preprocessed and co-processed pharmaceutical ingredients.
Biopharmaceutical companies are also inclined towards use of excipients for enhancing the stability and add bulk to biologics.
Enquire before Buying this Exclusive Report by CMI: https://www.coherentmarketinsights.com/insight/talk-to-analyst/124
Key takeaways of the market:
The global pharmaceutical excipients market is expected to expand at a CAGR of 6.9% during the forecast period (2016–2024). The rise in market for oral formulation is expected to favor the market for pharmaceutical excipients over the forecast period. This has been supported by the introduction of different types of oral dosage for having variations in release timing and coating properties.
The binder functionality type segment in the global pharmaceutical excipients market was estimated to be the largest in 2015 and is expected to dominate the market throughout the forecast period in terms of value. This is expected to grow in the near future on the backdrop of rise in demand for oral dosage forms globally.
In terms of product type, the plant chemistry type segment is expected to expand at a significant CAGR of 7.8% during the forecast period. The growing demand for plant products are projected to favor the market for pharmaceutical excipients market in the near future
The global pharmaceutical excipients market is characterized by strategic research and development and advancements in the excipients processing, also the organizations involved in the manufacturing of the excipients are now inclined towards product development to expand their product portfolio. For instance, according to pharmaceutical technology, in 2012, Ashland announced the expansion of production of Polyplasdone cross-linked polyvinylpyrrolidone (PVPP) in Texas City manufacturing facility.
Some of the major players are Innophos Holdings Inc., The Dow Chemical Company, The Lubrizol
Corporation, Wacker Chemie AG, and Ashland Inc., BASF SE, and Evonik Industries AG
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel : +1-206-701-6702
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Excipients Market to Surpass US $9.8 Billion by 2024 here
News-ID: 592063 • Views: 318
More Releases from CMI - Pharmaceutical Research
Global Pulmonary Arterial Hypertension (PAH) Market - Pfizer, Inc., Actelion Pha …
Pulmonary hypertension or PH is a condition in which the blood pressure rises in the pulmonary artery, vein, or capillaries (collectively known as lung vasculature), which might lead to shortness of breath, fainting, leg swelling, and dizziness, among others. Pulmonary hypertension may be a relentless disease with a noticeable reduction in exercise tolerance. Pulmonary arterial hypertension or PAH indicates that the patient has high blood pressure in arteries that carry
Betaxolol Market - Size, Share, Growth, Outlook, and Trends Analysis 2018–2026
Betaxolol is a racemic mixture and beta-adrenergic receptor inhibitor used to treat patients with chronic open-angle glaucoma or ocular hypertension. It was first approved by the U.S. Food and Drug Administration (FDA) in 1989, as an oral tablet. Betaxolol is used either alone or in combination with other medicines to lower down the pressure within the heart or eye. In the heart, Betaxolol decreases the cardiac contractility and rate selectively
Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2 …
Cervical cancer develops in women’s cervix, and mainly affects sexually active women aged between 30 and 45. Cervical cancer often shows no symptoms in early stages. However, the death rate of cervical cancer can be significantly reduced with use of Pap test (Papanicolaou test): a screening procedure which can detect the changes in the cervix before the cancer develops. There are different types of cervical cancer, out of which two
More Releases for Excipients
Global Pharmaceutical Excipients Market to Witness Growth Through 2021, Due to I …
The global Pharmaceutical Excipients market focuses on encompassing major statistical evidence for the Pharmaceutical Excipients industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Pharmaceutical Excipients study also shifts its attention
Biopharmaceuticals Excipients Market 2020-2030
Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others Purchase the full report or download free sample pages: https://www.visiongain.com/report/biopharmaceuticals-excipients-market-2020-2030/ The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.2%. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 162-page report you will receive 85 charts- all unavailable elsewhere. The 162-page report provides
Global Pharmaceutical Excipients Market Research Report
This report studies the global Pharmaceutical Excipients market status and forecast, categorizes the global Pharmaceutical Excipients market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Ashland BASF DOW Roquette FMC Evonik Lubrizol Associated British Foods Croda International Archer Daniels Midland Geographically, this
Excipients Market Report 2018: Segmentation by Type (Organic Excipients, Inorgan …
Global Excipients market research report provides company profile for Evonik, Lubrizol, Associated British Foods, Croda International, Archer Daniels Midland, Ashland, BASF, DOW, Roquette, FMC and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The
Nutraceutical Excipients Market
For their nutritional and medicinal advantages, several bioactive compounds and ingredients are being used in the production of medical foods, functional foods and dietary supplements. As health consciousness among consumers increases, the demand for dietary supplements will witness an upsurge. In order to attain a stabilized manufacturing of these products, a range of nutraceutical excipients will be utilized. The key role of nutraceutical excipients in reducing the bioactivity during the
Pharmaceutical Excipients Research 2017-2021
"Global Pharmaceutical Excipients Market 2017-2021" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. . . Description- '